EN 
IT 
PT 
ES 
DE 
The management of mood and behavior disorders, particularly in people with Autism Spectrum Disorder (ASD), is a major challenge. Traditional therapeutic approaches focus primarily on behavioral interventions, but interest in non-invasive neurobiological treatments is growing. Among them, the Radio Electric Asymmetric Conveyer (REAC)® Technology It stands out for its potential in reducing the symptoms of mood disorders and improving functional abilities in children with ASD.
How REAC® TECHNOLOGY works
REAC® TECHNOLOGY employs non-invasive neurobiological stimulation designed to optimize endogenous bioelectric activity. This process aims to improve neurotransmission and enhance the brain's ability to respond to environmental stresses. The treatment uses a specific device, capable of modulating and reprogramming endogenous bioelectricity in a personalized way, promoting a neurophysiological balance and relieving the symptoms related to different disorders.
Clinical evidence
Recent research has highlighted the effectiveness of REAC® TECHNOLOGY protocols in treating ASD symptoms. In a study of 46 children diagnosed with ASD, there was a significant improvement in symptoms measured through the Autism Treatment Evaluation Checklist (ATEC). After treatment, a reduction in anxiety, stress and depressive symptoms was observed.
A further study highlighted advances in children's functional skills, as assessed by the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test (PEDI-CAT). Improvements included an increase in daily skills, social cognition, and overall quality of life.
The Role of Mood Disorders in ASD Patients
Anxiety and depression, frequently present in people with ASD, can aggravate major symptoms and negatively affect overall balance. REAC® TECHNOLOGY has been shown to be beneficial in strengthening resilience to stress and regulating emotions, improving the brain's allostatic response.
In addition, REAC Neurobiological Modulation treatments have shown substantial benefits in motor, cognitive and behavioral abilities. These improvements have been reported by caregivers using assessment tools such as the Autism Profiling Questionnaire (APQ), which has shown progress in a number of areas.
Conclusions
Integrating REAC therapeutic protocols into treatment plans for ASD represents a promising opportunity to address mood and behavior disorders. The non-invasive nature of REAC® TECHNOLOGY, combined with its ability to improve functional skills and alleviate emotional disorders, makes it a valuable tool in ASD management.
It is essential to continue with further research to standardize protocols and optimize the application of REAC® TECHNOLOGY. This approach could significantly contribute to improving the quality of life and functional independence of people with ASD.
By adopting innovative solutions such as REAC® TECHNOLOGY, a more comprehensive and effective therapeutic system can be built to address the complex challenges of autism spectrum disorders and associated mood and behavior disorders.
Thank you for your support!